{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T04:08:47Z","timestamp":1780805327114,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.jpba.2013.07.016","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T17:02:54Z","timestamp":1374771774000},"page":"145-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["LC\u2013ESI-MS\/MS quantification of 4\u03b2-hydroxycholesterol and cholesterol in plasma samples of limited volume"],"prefix":"10.1016","volume":"85","author":[{"given":"Yaodong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Edom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naidong","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rao","family":"Mamidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng-Keang","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2013.07.016_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2147\/tcrm.1.1.3.53600","article-title":"Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4","volume":"1","author":"Zhou","year":"2005","journal-title":"Therapeutics and Clinical Risk Management"},{"issue":"2","key":"10.1016\/j.jpba.2013.07.016_bib0010","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1208\/s12248-008-9037-4","article-title":"Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical","volume":"10","author":"Sinz","year":"2008","journal-title":"AAPS Journal"},{"key":"10.1016\/j.jpba.2013.07.016_bib0015","first-page":"414","article-title":"Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada","year":"1994","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.jpba.2013.07.016_bib0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.pharmtox.38.1.389","article-title":"In vitro and in vivo drug interactions involving human CYP3A","volume":"38","author":"Thummel","year":"1998","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.jpba.2013.07.016_bib0025","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1365-2125.2009.03548.x","article-title":"Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A","volume":"68","author":"Turpault","year":"2009","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jpba.2013.07.016_bib0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2125.1989.tb03516.x","article-title":"The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction","volume":"28","author":"Ged","year":"1989","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jpba.2013.07.016_bib0035","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00228-003-0690-3","article-title":"Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals","volume":"59","author":"Galteau","year":"2003","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jpba.2013.07.016_bib0040","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0009-9236(98)90084-4","article-title":"Urinary excretion of 6 beta-hydroxycortisol as an in vivo marker for CYP3A induction: applications and recommendations","volume":"63","author":"Kovacs","year":"1998","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.jpba.2013.07.016_bib0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/FPC.0b013e3282f50ee9","article-title":"4Beta-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians","volume":"18","author":"Diczfalusy","year":"2008","journal-title":"Pharmacogenetics and Genomics"},{"key":"10.1016\/j.jpba.2013.07.016_bib0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2125.2010.03773.x","article-title":"4\u03b2-Hydroxycholesterol, an endogenous marker of CYP3A4\/5 activity in humans","volume":"71","author":"Diczfalusy","year":"2011","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jpba.2013.07.016_bib0055","doi-asserted-by":"crossref","first-page":"709","DOI":"10.5414\/CPP47709","article-title":"4Beta-hydroxycholesterol as a marker of CYP3A4 inhibition in vivo \u2013 effects of itraconazole in man","volume":"47","author":"Lutjohann","year":"2009","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.jpba.2013.07.016_bib0060","first-page":"991","article-title":"Biotransformation of tirilazad in human: 2. Effect of ketoconazole on tirilazad clearance and oral bioavailability","volume":"277","author":"Fleishaker","year":"1996","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.jpba.2013.07.016_bib0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/clpt.2009.72","article-title":"Plasma 4beta-hydroxycholesterol: an endogenous CYP3A metric?","volume":"86","author":"Tomalik-Scharte","year":"2009","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.jpba.2013.07.016_bib0070","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/clpt.2011.53","article-title":"Evaluation of 6\u03b2-hydroxycortisol, 6\u03b2-hydroxycortisone, and a combination of the two as endogenous probes for inhibition of CYP3A4 in vivo","volume":"89","author":"Peng","year":"2011","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.jpba.2013.07.016_bib0075","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1177\/0091270009360041","article-title":"Does the long plasma half-life of 4beta-hydroxycholesterol impact its utility as a cytochrome P450 3A (CYP3A) metric?","volume":"50","author":"Yang","year":"2010","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jpba.2013.07.016_bib0080","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3109\/00498254.2011.560295","article-title":"Evaluation of a chimeric (uPA+\/+)\/SCID mouse model with a humanized liver for prediction of human metabolism","volume":"41","author":"de Serres","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jpba.2013.07.016_bib0085","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nbt1326","article-title":"Robust expansion of human hepatocytes in Fah\u2212\/\u2212\/Rag2\u2212\/\u2212\/Il2rg\u2212\/\u2212 mice","volume":"8","author":"Azuma","year":"2007","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.jpba.2013.07.016_bib0090","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/978-1-60761-688-7_27","article-title":"Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity","volume":"640","author":"Strom","year":"2010","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/j.jpba.2013.07.016_bib0095","doi-asserted-by":"crossref","first-page":"38685","DOI":"10.1074\/jbc.M105127200","article-title":"Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4","volume":"276","author":"Bodin","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jpba.2013.07.016_bib0100","first-page":"117","article-title":"Studies on cholesterol ester formation and hydrolysis in liver disease: a selective review","volume":"52","author":"Simone","year":"1979","journal-title":"Yale Journal of Biology and Medicine"},{"key":"10.1016\/j.jpba.2013.07.016_bib0105","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0022-2275(20)39708-X","article-title":"Identification and quantitation of cholest-5-ene-3 beta,4 beta-diol in rat liver and human plasma","volume":"36","author":"Breuer","year":"1995","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.jpba.2013.07.016_bib0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/abio.1995.1110","article-title":"Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry","volume":"225","author":"Dzeletovic","year":"1995","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/j.jpba.2013.07.016_bib0115","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jpba.2011.03.017","article-title":"A validated liquid chromatography\u2013tandem mass spectrometry method for the quantitative determination of 4\u03b2-hydroxycholesterol in human plasma","volume":"55","author":"van de Merbel","year":"2011","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.jpba.2013.07.016_bib0120","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1021\/tx2001898","article-title":"Quantification of 4-beta-hydroxycholesterol in human plasma using automated sample preparation and LC\u2013ESI-MS\/MS analysis","volume":"24","author":"Goodenough","year":"2011","journal-title":"Chemical Research in Toxicology"},{"key":"10.1016\/j.jpba.2013.07.016_bib0125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.steroids.2006.10.005","article-title":"Synthesis of pyridine-carboxylate derivatives of hydroxysteroids for liquid chromatography\u2013electrospray ionization-mass spectrometry","volume":"72","author":"Yamashita","year":"2007","journal-title":"Steroids"},{"key":"10.1016\/j.jpba.2013.07.016_bib0130","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1194\/jlr.D800017-JLR200","article-title":"Highly sensitive analysis of sterol profiles in human serum by LC\u2013ESI-MS\/MS","volume":"49","author":"Honda","year":"2008","journal-title":"Journal of Lipid Research"},{"issue":"10","key":"10.1016\/j.jpba.2013.07.016_bib0135","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.trac.2008.09.002","article-title":"Quantitative determination of endogenous compounds in biological samples using chromatographic techniques","volume":"27","author":"van de Merbel","year":"2008","journal-title":"Trends in Analytical Chemistry"},{"key":"10.1016\/j.jpba.2013.07.016_bib0140","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1208\/s12248-009-9100-9","article-title":"Workshop report and follow-up \u2013 AAPS workshop on current topics in GLP bioanalysis: assay reproducibility for incurred samples \u2013 implications of Crystal City recommendations","volume":"11","author":"Fast","year":"2009","journal-title":"AAPS Journal"},{"key":"10.1016\/j.jpba.2013.07.016_bib0145","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1021\/ac1015497","article-title":"Dansylation of unactivated alcohols for improved mass spectral sensitivity and application to analysis of cytochrome P450 oxidation products in tissue extracts","volume":"82","author":"Tang","year":"2010","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.jpba.2013.07.016_bib0150","doi-asserted-by":"crossref","first-page":"18426","DOI":"10.1074\/jbc.M111.240457","article-title":"Inhibition of human cytochrome P450 3A4 by cholesterol","volume":"286","author":"Shinkyo","year":"2011","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jpba.2013.07.016_bib0155","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/rcm.1790","article-title":"Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography\/mass spectrometry: necessity or not?","volume":"19","author":"Stokvis","year":"2005","journal-title":"Rapid Communications in Mass Spectrometry"},{"key":"10.1016\/j.jpba.2013.07.016_bib0160","series-title":"Proceedings of the 59th ASMS conference on mass spectrometry and allied topics, Poster # 667","article-title":"Determination of an endogenous biomarker \u2013 4\u03b2-hydroxycholesterol \u2013 in K2EDTA human plasma by LC\u2013MS\/MS","author":"Lin","year":"2011"},{"issue":"11","key":"10.1016\/j.jpba.2013.07.016_bib0165","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s11745-001-0843-0","article-title":"Comparison of the Bligh and Dyer and Folch methods for total lipid determination in a broad range of marine tissue","volume":"36","author":"Iverson","year":"2001","journal-title":"Lipids"},{"key":"10.1016\/j.jpba.2013.07.016_bib0170","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ab.2008.05.037","article-title":"Liquid chromatography\u2013tandem mass spectrometry determination of plasma 24S-hydroxycholesterol with chromatographic separation of 25-hydroxycholesterol","volume":"381","author":"DeBarber","year":"2008","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/j.jpba.2013.07.016_bib0175","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1021\/ac0624086","article-title":"Quantitative method for the profiling of the endocannabinoid metabolome by LC\u2013atmospheric pressure chemical ionization-MS","volume":"79","author":"Williams","year":"2007","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.jpba.2013.07.016_bib0180","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s00216-010-4103-z","article-title":"Simultaneous measurement of three N-acylethanolamides in human bio-matrices using ultra performance liquid chromatography\u2013tandem mass spectrometry","volume":"398","author":"Lam","year":"2010","journal-title":"Analytical and Bioanalytical Chemistry"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513003129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513003129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T02:45:13Z","timestamp":1646189113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708513003129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":36,"alternative-id":["S0731708513003129"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2013.07.016","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LC\u2013ESI-MS\/MS quantification of 4\u03b2-hydroxycholesterol and cholesterol in plasma samples of limited volume","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2013.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}